Use of Engineered Regulatory T-Cells to Induce Immunologic Tolerance: Path to the Clinic

Time: 11:30 am
day: Focus Day - Track A - Afternoon

Details:

  • Rational and preliminary data to support the use of antigen-specific Tregs as a therapeutic approach
  • Engineering technologies to improve Treg efficacy in the clinical application

 

 

 

Speakers: